DOW vs SRPT · P/E 74, rev $39.97B vs rev $1.13B
Dow Inc (DOW) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported DOW revenue for 2025-12-31 was $39.97B. Net income was -$2.44B. Revenue was down 7.0% from 2024-12-31 to 2025-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the DOW and SRPT stock pages for the full models.
Not investment advice.